Comparative in-vitro activity of levofloxacin against Chlamydia spp.

被引：3

作者：

Donati, M

Rumpianesi, F

Marchetti, F

Sambri, V

Cevenini, R ^{[1
]}

机构：

[1] Osped S Orsola, DMCSS, Sez Microbiol, Bologna, Italy

[2] Hoechst Mar Roussel, Dept Med, Milan, Italy

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1998年 / 42卷 / 05期

关键词：

D O I：

10.1093/jac/42.5.670

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：670 / 671

页数：2

共 6 条

[1]

CEVENINI R, 1987, FEMS MICROBIOL LETT, V42, P47, DOI 10.1111/j.1574-6968.1987.tb02297.x

[2] The clinical pharmacokinetics of levofloxacin [J].

Fish, DN ;

Chow, AT .

CLINICAL PHARMACOKINETICS, 1997, 32 (02) :101-119

[3] INVITRO ACTIVITIES OF 5 QUINOLONES AGAINST CHLAMYDIA-PNEUMONIAE [J].

HAMMERSCHLAG, MR ;

HYMAN, CL ;

ROBLIN, PM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) :682-683

[4] OFLOXACIN VERSUS DOXYCYCLINE FOR TREATMENT OF CERVICAL INFECTION WITH CHLAMYDIA-TRACHOMATIS [J].

HOOTON, TM ;

BATTEIGER, BE ;

JUDSON, FN ;

SPRUANCE, SL ;

STAMM, WE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) :1144-1146

[5] Chlamydiae as pathogens: New species and new issues [J].

Peeling, RW ;

Brunham, RC .

EMERGING INFECTIOUS DISEASES, 1996, 2 (04) :307-319

[6] In vitro activity of trovafloxacin against Chlamydia pneumoniae [J].

Roblin, PM ;

Kutlin, A ;

Hammerschlag, MR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :2033-2034

← 1 →